Griffith University is bidding a grateful farewell to community champion and Director of the Institute for Glycomics, Professor Mark von...
Repurposed medications may guide future strategies for COVID-19 treatment.
Using convalescent plasma, Griffith University researchers have identified how it may be possible to make a future vaccine that will provide protection against all major strains of COVID-19
Bendigo Bank Paradise Point Community Bank Branch, long-standing supporters of Griffith University’s Institute for Glycomics, have donated $10,000 in funding...
Australian and German researchers from the international consortium iCAIR® (Fraunhofer International Consortium for Anti-Infective Research), comprising of Griffith University’s Institute...
Four teams of expert scientists from Griffith University’s Institute for Glycomics are targeting the virus SARS-CoV-2 to discover new vaccines...
Director and Head of Research for the Institute for Glycomics Professor Mark von Itzstein AO has been honoured with the Gold Coast Citizen of the Year award.
Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.
Researchers develop drug target to tackle multi-drug resistant lung bacterium.
Griffith University will use a $2.95 million NHMRC grant to take a unique focus on targeting sugar interactions to prevent...
